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Background: Primary Sjo¨gren’s syndrome (pSs) is an autoimmune rheumatic disease
that may express in a small number of patients a spectrum of lymphoproliferative
diseases. The aim of this study was to describe clinical, imaging and pathology
features of the extranodal marginal zone B-cell lymphoma (MZCL) of the lung of
mucosa-associated lymphoid tissue (MALT) type in patients with pSs.
Methods: All patients (N ¼ 10) with biopsy proven MZCL of the lung of MALT type
diagnosed in a tertiary teaching hospital during the last 7 years were studied.
Results: Seven patients had pSs. Almost all patients presented an indolent clinical
course, contrasting strongly with the spectacular radiological findings in both chest
roentgenograms and computed tomography. Pathology infiltration patterns observed
were either nodular, peribronchial–perivascular, alveolar, or interstitial. Immuno-
histochemical study in all cases showed B cell phenotypes. Immunoglobulin lightElsevier Ltd. All rights reserved.
mography; BALT, bronchus associated lymphoid tissue; HIV, human immunodeficiency virus;
of the lung; MALT, mucosa-associated lymphoid tissue; pSs, primary Sjo¨gren’s syndrome
5832361; fax: +30 210 5326414.
(S.A. Papiris).
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Marginal zone B-cell lymphoma in Sjo¨gren’s syndrome 85chain restriction was demonstrated in all patients. Monoclonal IgM(k) was evident in
5/7, IgM(l) in 1/7 and IgG (k) in 1/7 of patients.
Conclusions: Lung MZCL associated with pSs are characterized by an important
dissociation between clinical expression and radiological pattern. Clinical presenta-
tion and imaging features are not specific. Therefore, histologic documentation is
mandatory to ensure diagnosis. Various chemotherapeutic agents in combination
with rituximab lead to partial or complete remission in the majority of patients.
& 2006 Elsevier Ltd. All rights reserved.Background
The presence of mucosa-associated lymphoid tissue
(MALT) in the lung was first described by Bienen-
stock and colleagues in 1973, as bronchial and
bronchiolar subepithelial aggregates of lymphoid
tissue named bronchus-associated lymphoid tissue
(BALT).1 However, the presence of BALT in normal
human lungs is still debatable2 and it is actually
considered that the human lung has the capacity to
form BALT under certain stimulatory conditions
such as chronic lung infections, autoimmune
disorders and especially Sjo¨gren’s syndrome (SS),
human immunodeficiency virus (HIV) or other viral
infections.2 BALT is thought to participate in
immunologic reactions to airborne antigens, and
can be the source of various pathologic lesions
ranging from benign hyperplasia to lymphoid
malignancy.3
Primary Sjo¨gren’s syndrome (pSs), an autoim-
mune epithelitis, is a chronic, slowly progressive
inflammatory autoimmune disease characterized
by: (a) a T lymphocytic infiltration of the exocrine
glands and epithelia in multiple sites, including
those of the large and small airways, leading to
diminished or absent glandular secretions and to a
more or less generalized mucosal dryness, and (b) a
marked B lymphocytic cell hyperactivity mani-
fested by various serum autoantibodies.4–6 pSs is
considered at the crossroads of autoimmune dis-
ease and lymphoid malignancy since it may express
in a small number of patients (E5%), a spectrum
of lymphoproliferative diseases, including MALT
lymphomas.7–11
MALT-type lymphomas of the lung, also known as
BALT lymphomas, are very rare malignancies. MALT
lymphomas originate from the marginal zone B cells
that surround the mantle zone and germinal centre
and are currently classified as a distinct subgroup of
non-Hodgkin’s lymphomas under the term extra-
nodal marginal zone B-cell lymphoma (MZCL) of
MALT-type.12 MALT-type lymphomas have also been
associated with other autoimmune disorders, as
well as Helicobacter pylori infection, HIV infection,
common variable immunodeficiency, chronic activehepatitis C, Borrelia burgdoferi infection, and
other chronic inflammatory conditions but may also
develop in patients with no pre-existing dis-
ease.12–19 Previously published series of pulmonary
MZCLs had occasionally included patients with
pSs.13,20–22 However, review of the literature shows
that MZCLs associated to pSs have not been
thoroughly examined so far. The aim of the present
study was to describe clinical, imaging and histo-
pathology features in Sjo¨gren’s associated MZCLs of
MALT-type of the lung.Patients and methods
Patients
All patients with biopsy documented primary MZCL
of MALT-type of the lung, diagnosed during the last
7 years in the Pathology department of the
‘‘Evangelismos’’ General Hospital, Athens, Greece,
were retrospectively studied. Medical charts,
radiographic findings and pathology specimens
were reviewed. The protocol of the study was
approved by the Ethics Committee of the Hospital.
Chest roentgenograms and chest-computed
tomography (CT) examination
Chest roentgenograms and CT images were avail-
able in all patients and were retrospectively
reviewed by two experienced readers (KM, SP) by
consensus. CT images were reviewed on hard copies
in all patients at mediastinal windows (level 0 to
40HU; width 400–500) and lung windows (level
600 to 700HU; width 1000–1500). High-resolution
(HR) CT slices were available in all patients. Images
were evaluated for pulmonary nodules (p3 cm in
diameter), micronodules (p5mm), masses
(43 cm), alveolar opacifications with or without
air bronchograms, ground glass opacities defined as
areas of increased lung attenuation without ob-
scuration of the lung structures, cavities, bronchial
changes (dilatation and thickening), lymph node
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fined as described in the radiological nomencla-
ture.23 Disease distribution was also recorded.Pathology
All pathology specimens were reviewed by an
experienced pathologist (DR). In order to define
CT-pathologic correlations, the predominant site
and type of pathologic changes were determined
according to the recently described histologic
infiltration patterns: (1) nodular, unique or multi-
ple, confluent; (2) peribronchial–peribronchiolar
and perivascular, when the lymphoma cells present
along bronchial–bronchiolar and vascular bundles;
(3) alveolar, when lymphoma cells filled the
alveolar spaces; (4) interstitial, when lymphoma
cells were infiltrating alveolar septa; and (5)
pleural, when lymphoma cells were present in the
pleura.24 All biopsies had been fixed in formalde-
hyde in 0.1M phosphate buffer at pH 7.2 U and
after dehydration, embedded in paraffin. Serial
sections 3 mm thick were cut, and tissue specimens
were disposed for histological analysis. Multiple
sections were used for each staining. Histochem-
istry with hematoxylin-eosin was performed for the
identification of the predominant site and type of
the pathologic changes. Primary MZCL of MALT-type
of the lung was defined as an infiltration of the lung
parenchyma by lymphocytes with lymphoplasma-
cytoid or centrocytoid appearance that may be
associated with germinal centres and lymphoe-
pithelial foci. In all patients the pathologic diag-
noses were definitely confirmed by immuno-
histochemistry. Formalin-fixed, paraffin-embedded
tissue sections were used for immunohistochemical
analysis in all cases. The antibody panel included
CD3 (polyclonal 1:2000, Dako, Denmark), CD5 (4C7
1:1000, Novocastra, UK), CD10 (56C6 1:50, Novo-
castra, UK), CD20 (L26, Dako, Denmark), CD21 (1F8
1:1600 pepsin, Becton Dickinson, USA), CD23
(MH016 1:50, DAKO, Denmark), CD79a (clone JCB
117 1:50 Neomarkers) CD4 (clone 4B12 1:20) DAKO)
CD8 (clone 144B 1:25 DAKO) bcl-2 (124, 1:800,
DAKO, Denmark), bcl-6 (PG-B6P 1:20, DAKO Den-
mark), cyclin D1 (DCS-6 1:80 overnight, DAKO,
Denmark), kappa (polyclonal 1:600,000, DAKO,
Denmark), lambda (polyclonal 1:400,000, DAKO,
Denmark), IgM (1:2,000 A0426, DAKO, Denmark),
IgG (1:8000 A0423, DAKO, Denmark) and Ki-67
(MIB-1, 1:2000 citrate buffer/steaming, DAKO,
Denmark). Cam5.2 (prediluted Becton Dickinson)
The immunohistochemical staining was performed
using a labelled streptavidin-biotin procedure in
Techmate 500 automatic immunostainer (DAKO,Denmark). Briefly, 3 mm sections were incubated
with unconjugated primary antibodies after antigen
retrieval, followed by incubation with biotinylated
secondary antibodies and streptavidin–conjugated
peroxidase. The colorimeric reaction was com-
pleted with diaminobenzidine (Sigma). Antigen
retrieval was performed with the heat-induced
epitope retrieval method in target retrieval solu-
tion (DAKO) at an appropriate pH.Results
MZCLs of MALT-type of the lung were diagnosed in
10 patients, 9 females and 1 male. The diagnosis of
MZCL of MALT-type of the lung was made through
video-assisted lung biopsy in all of them. Seven
female patients fulfilled the criteria for pSs25 with
disease lasting more than 7 years. The clinical,
imaging and pathology features of these seven
patients were further analyzed.
Clinical findings
All patients were Caucasians. None of the patients
was immunocompromised and all were HIV nega-
tive. Mild dry cough was a predominant symptom in
all patients with pSs. Moderate weight loss and easy
fatigue was reported by one patient and mild
breathlessness on exertion by one other. Flexible
fiberoptic bronchoscopy was performed in all
patients and revealed no remarkable endobronchial
findings in any of them. Bronchial washing cytology
and microbiology studies were negative for malig-
nancy and infection, respectively. All patients
experienced an uncomplicated postoperative
course and adequate samples were obtained in all
of them. Physical examination, blood studies and
CT of the abdomen and bone marrow biopsy
revealed no extrapulmonary involvement. All pa-
tients received various chemotherapeutic regimens
achieving partial or complete remission and are still
alive in follow-up.
Imaging findings
Chest roentgenograms: Pulmonary lesions were
observed in all lung fields with a random distribu-
tion and were multiple and bilateral in all.
Calcifications, pleural effusion, significant lympha-
denopathy and cavitations compatible with tumour
necrosis were never observed. The chest roent-
genographic appearance in most of the patients
was that of patchy bilateral infiltrates mainly
peripheral in distribution. In one patient multiple
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and in another micronodules plus infiltrates were
observed. In one patient a large right perihilar
mass-like density with radiating bilateral linear
densities suggesting lymphangiitis was evident. In
this patient previous chest roentgenograms re-
vealed that this lesion gradually developed from
an ill defined density at the level of the middle lobe
(Fig. 1(A–D)).
Computed tomography
In all patients the HR CT appearance was more
revealing of the pattern of the disease develop-
ment which appeared pleomorphic and variegated
(Fig. 1(A–D)). ‘‘The lesions were randomly distrib-Figure 1 (A) Posteroanterior chest roentgenogram demonstr
lobe (asterisk). (B) Posteroanterior chest roentgenogram of
right perihilar opacity compared to A (asterisks). (C) Subse
reveals that the right perihilar mass (asterisks) has grown fu
suggesting linphangitis (arrows). The straight interface indic
fissure). Interstitial thickening is now evident in the left lu
patient reveals a large mass-like opacity in the middle lobe (
Diffuse peribronchial nodules of 2–3mm (open arrowheads)
also seen bilaterally (patient no 2).uted though there was a trend of more extensive
involvement of the lower lobes. Confluent alveolar
opacifications with extensive peribronchial distri-
bution, usually associated with air bronchograms
were observed in 5 patients (Fig. 1(D)). Multiple
lung nodules (p3 cm in diameter), and/or masses
(43 cm in diameter), were found in 4 patients
(Fig. 2). Peripheral, usually multiple alveolar
opacifications with or without air bronchograms
(Fig. 3) were a common finding observed in 6
patients. Ground glass attenuation was present in
almost all the radiological patterns already de-
scribed. Micronodules were observed in 4 patients
(Fig. 1(D)) and mild bronchial wall thickening
was seen in another 4. Bronchial dilatation was
further observed in 2 patients. Thin-walled cysticates a small ill-defined density at the level of the middle
the same patient 2 years later reveals a large ill-defined
quent posteroanterior chest roentgenogram 1 year later
rther and has developed linear densities in the periphery
ated by the open arrows suggests lobar boarders (minor
ng. (D) The corresponding computed tomography of this
asterisks) with considerable bronchial dilatation (arrow).
and interstitial septal thickening (block arrowheads) are
ARTICLE IN PRESS
Figure 2 Computed tomography at the level of the
middle lung zone, demonstrates multiple bilateral lung
nodules (open arrows) and masses (asterisks)—(patient
No 1).
Figure 3 High-resolution computed tomography at the
level of the pulmonary hila, reveals multiple air space
opacities of peribronchial distribution with air broncho-
grams (arrows)—(patient No 4).
S.A. Papiris et al.88structures of a diameter of 1–3 cm were identified
in 2 patients (never smokers). Lymph nodes of 5 and
6mm were seen in the mediastinum in 2 patients
not considered as significant since their short axis
diameter was less than 10mm.Pathology findings
The overall histological architectural pattern was
similar in these 7 cases. At low magnification all
lesions showed a denser pattern in their central
region and a more disperse, confluent or nodular
infiltrate toward the periphery (Fig. 4(A)). The
predominant pattern of growth was interstitial withprominent perivascular (Fig. 4(B)) and peribron-
chial-peribronchiolar (Fig. 4(C)) expansion and was
evident in all patients. Airways and vessels of all
sizes available were surrounded. In four cases the
lymphoid infiltrates spilled over the air spaces in an
intraalveolar or an interstitial pattern or sur-
rounded normal pulmonary structures including
the adjacent visceral pleura (one patient) and
bronchial cartilage (one patient). In five cases the
lymphoid infiltrates presented a mass-forming
pattern of development with extensive consolida-
tion of the lung parenchyma. Small parenchymal
nodules were commonly observed. Small airways
when available appeared compressed in all cases.
The bronchial epithelium was infiltrated in differ-
ent sites by the lymphoid cells. In almost all cases
there were reactive-appearing germinal centres,
scattered throughout the infiltrate or at its
periphery. In none of our patients did we observe
amyloid deposits on histology.
Immunohistochemical studies in all cases have
shown that the majority of infiltrating lymphocytes
bear the B cell phenotypes CD20, CD79a and
absence of CD5, CD23, CD10 antigens as well as
bcl-6 and cyclin D1 proteins. In addition few CD3
small lymphocytes were also observed. The
majority of them were found to be CD4 lympho-
cytes. The lymphoepithelial nature of the lesions
was demonstrated by the positive staining with the
anticytokeratin antibody CAM5.2 (Fig. 5). Immuno-
globulin light chain restriction was demonstrated in
all patients. Monoclonal IgM(k) was evident in 5/7,
IgM(l) in 1/7 and IgG (k) in 1/7. Morphological and
immunohistochemical findings of all seven biopsy
specimens were diagnostic of primary MZCL of
MALT-type of the lung according to Revised Eur-
opean American Lymphoma classification.26Discussion
As far as we know, this is the first study focusing on
MZCL of MALT-type of the lung associated with pSs
and the largest series of patients with both entities
studied for radiological and pathology findings.
According to its results, radiographic features of
MZCL in pSs patients are non-specific and the
course of the disease quite indolent, even in cases
with apparently ‘‘aggressive’’ roentgenographic
patterns.
The overall imaging features are similar to those
reported in previous studies on patients with MZCL
of the lung both associated and not associated with
pSs.20–22,27–30 The most common findings on chest
roentgenogram were patchy infiltrates commonly
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Figure 5 Lymphoepithelial lesion demonstrated by im-
munohiostochemistry using anticytokeratin antibody
(CAM5.2 Envison  400).
Figure 4 Histopathology of MALT-type pulmonary lymphoma. (A) A dense lymphoid infiltrate affects the pulmonary
parenchyma and focally invades the alveolar septa. Both, nodular confluent and interstitial infiltration patterns of
development (H&E,  100). (B) Angiocentric (perivascular) and diffuse alveolar infiltration patterns of development of
the lymphomatoid cells (H&E,  200). (C) Bronchocentric (peribronchiolar) infiltration pattern of development of the
lymphomatoid cells (H&E,  200).
Marginal zone B-cell lymphoma in Sjo¨gren’s syndrome 89bilateral, and irregularly distributed in both lungs.
Nodules, micronodules and a mass-like density with
a bilateral lymphangitic pattern were also ob-served. Overlapping between these various pat-
terns was also seen. However, in the last patient
with the lymphangiitic pattern, the study of
previous chest roentgenograms revealed that this
lesion gradually developed from an ill-defined
density at the level of the middle lobe, enlarging
locally and spreading bilaterally (Fig. 1(A–D)). All
CT lesions were observed in multiple sites of the
lungs in the majority of patients. This pattern is
probably associated with the fact that lymphoid
tissue, when developed in bronchial mucosa,
is not contained within organized lymphoid
structures but rather develops irregularly and
distributes diffusely.13,21 In the present study,
cavitation of the pulmonary nodules or masses
was not observed. Investigators have already
showed besides that apparent cavitations
occasionally seen at CT in some patients were in
fact dilated bronchi within the area of the
lymphoma.29 The prognostic significance of bron-
chial, pleural and vessel involvement in MALT
lymphomas remains still uncertain.
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occasional examination in all cases and dry cough
of mild intensity was the commonest and most of
the times the only complaint leading to chest
imaging. Since cough is considered by most pSs
patients as their ‘‘baseline status,’’31 it is pointed
out that routine chest radiological examination
should be regularly performed in these patients and
the presence of pulmonary infiltrates should
prompt the consideration of lymphoma in the lung.
These findings are in agreement with previously
reported results on pulmonary MZCL not associated
with pSs.12,13,16,21,22,27
The absence of significant lymphadenopathy in
the patients of the present study is in agreement
with previous studies.20,21,30 BALT-type lymphomas
characteristically remain localized to the lung for
long periods of time before being disseminated,
and when this occurs, other sites of MALT tissue are
preferentially involved.12 Lymph nodes are very
rarely involved in advanced disease and this feature
may assist in the differential diagnosis from other
lung involving lymphomas.32
Furthermore in this study, thin-wall cystic spaces
were present in two patients. Cystic spaces
associated with nodules, masses or infiltrates are
highly suggestive either of lymphoid interstitial
pneumonia (LIP) with associated bronchiolitis or of
pulmonary amyloidosis.33,34 Cystic spaces are the
result of an obstructive infiltration of small airways
with a valve mechanism that may be related either
to the LIP-bronchiolitis itself, or to amyloid
deposits.34 Since none of our patients presented
amyloid deposits on histology, cystic lesions are
more likely attributed to the previous lung involve-
ment by LIP-bronchiolitis. In this patient eventually
the MZCL of MALT-type of the lung developed on a
LIP background.
The high incidence of bilateral disease described
in our study is in accordance with the recent
findings of Ahmed and coworkers35 and could be
attributed to the following: first the indolent
course of the disease which leads to delay in the
diagnosis; second and more important, the pre-
sence of Sjo¨gren’s in all of our patients, a disease
characterized by bilateral hyperplasia of BALT, the
main site of development of MZCL. Furthermore,
the dissemination of the MZCL of MALT-type of the
lung among various BALT or MALT sites is an already
described feature of the disease behavior’’.35
The differential diagnosis of HRCT appearance
already described should include bronchioloalveo-
lar carcinoma, metastatic disease, other malignant
lymphoprolipherative diseases, Wegener’s vasculi-
tis, or cryptogenic organising pneumonia. The
absence of hilar and mediastinal lymph nodeenlargement, pleural effusions, and low attenua-
tion areas of necrosis in conjunction with the
absence of significant symptoms are characteristics
of patients with MZCL of MALT-type of the lung but
not specific enough for a confident diagnosis. Flow
cytometry analysis of bronchoalveolar lavage could
be suggestive of the disease but tissue documenta-
tion is warranted. Biopsies obtained through
bronchoscopy are proved inconclusive, therefore
surgical biopsy should be performed to ensure
diagnosis.35,36
On pathology examination, an extensive infiltra-
tion of the lung parenchyma by lymphoid cells was
observed in all cases. The histological pattern as
appeared in the surgical specimens’ examination
was similar among patients. In almost every
patient’s specimen, any type of previously de-
scribed pathologic changes such as nodular,
peribronchial–peribronchiolar and perivascular, al-
veolar and interstitial, as well as any combination
of the above was observed.24 No signs of aggres-
siveness were noted and no specific lesions attrib-
uted to SS have been observed. This might be
related in our opinion to the fact the surgeons were
specifically oriented towards the most evident
lesions in order to ensure diagnosis. In those sites
the lung parenchyma was totally replaced by the
lymphoma. Additionally, histological pattern of
growth correlated well with imaging appearance.
In this study, 7 female patients diagnosed with
MZCL of MALT-type of the lung, fulfilled the criteria
for pSs25 with disease lasting more than 7 years. As
far as the association of pSs with pulmonary
lymphoma is concerned, patients with SS have a
disproportionate tendency to develop lymphoproli-
ferative disorders, ranging from mixed monoclonal
cryoglobulinemia to malignant non-Hodgkin’s lym-
phoma (NHL).8 The development of the latter is
considered as the most serious complication of
SS.7–11 Lymphomas in pSs arise mainly in mucosal
extranodal sites including the salivary and lacrimal
glands, stomach and lung, and in most cases are
low-grade marginal zone B-cell lymphomas.8 On the
other hand, extranodal marginal zone lymphoma of
MALT-type is the most frequent type of NHL that
primarily involves the lung.12,37
The optimal treatment of the extranodal MZCLs
of MALT-type of the lung in the absence of any
prospective study remains unclear.38 In localized
disease surgical resection, either alone or in
combination with chemotherapy has been the
mainstay of treatment. Single or multiple che-
motherapeutic drug regimes have been used
successfully in other series as well as in this study
with extensive unilateral or bilateral disease.
Recent studies have shown that both oxaliplatin
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motherapy are promising therapeutic regimens for
these patients.39,40 Rituximab is another option
actually added to classic chemotherapeutic regi-
mens both as initial treatment or/and in case of
relapse.35 Transformation to high-grade lymphoma
is reported but not well documented and close
surveillance is imperative. Overall response to
treatment is satisfactory and prognosis is favour-
able.34,35,41
In conclusion, lung MZCL associated with pSs is
characterized by an important dissociation be-
tween clinical expression and radiological pattern.
The ample spectrum of radiographic manifestations
appears to reflect the ‘‘contingent’’ combination of
the histological infiltration patterns of disease
development. Clinical presentation and imaging
features are not specific enough to suggest MZCL of
the lung, therefore histological documentation is
mandatory to ensure diagnosis. Various chemother-
apeutic agents in combination with rituximab lead
to partial or complete remission in the majority of
patients.Acknowledgments
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